Bharat Biotech
Nation
Covaxin triggers higher antibody response in kids than adults: Bharat Biotech cites trial data
Express News Service
NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for the Covid vaccine -- only Covaxin...
Nation
Covaxin 77.8 per cent effective against COVID, 65.2 per cent against Delta variant: Study
By PTI
HYDERABAD: Bharat Biotech's vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed...
Nation
Ideal time for booster dose for COVID vaccine is 6 months after second dose: Bharat Biotech MD
By PTI
NEW DELHI: The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman...
Nation
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials
By PTI
HYDERABAD: Ocugen, Bharat Biotech's US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to...
Nation
WHO may approve Bharat Biotech’s Covaxin ‘within 24 hours: Official
The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing (EUL).
Nation
‘Can’t cut corners’: WHO seeks more data on Covaxin before decision on emergency use listing
By Express News Service
NEW DELHI: The wait for emergency use listing (EUL) of COVID-19 vaccine Covaxin by the World Health Organisation is set...
Nation
Intranasal Covid vaccine trials to likely end soon
By Express News Service
NEW DELHI: After receiving go-ahead for Covaxin for the two-years plus population by the drug regulator’s expert panel, Bharat Biotech...
Nation
Covid: Expert panel recommends emergency use approval for Covaxin in 2 to 18 age group
By PTI
NEW DELHI: An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children...
Nation
Expert panel endorses Covaxin for kids, vaccine may come in pre-filled syringes
Express News Service
NEW DELHI: An expert panel on Covid under the country’s apex drug regulator has approved administering Covaxin for kids and adolescents, paving the...
Nation
Bharat Biotech submits paediatric Covid vaccine data
Express News Service
BENGALURU: Bharat Biotech, the developer of the indigenously developed Covid-19 vaccine Covaxin, is said to have submitted its Phase II/III clinical trials data...
Latest News
Lok Sabha Elections: Shiv Sena (UBT) firm on contesting from Sangli, nobody should do anything that will help BJP: Sanjay Raut
MUMBAI: Shiv Sena (UBT) leader Sanjay Raut on Thursday said that his party was firm on contesting from Maharashtra's...